Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Myriad Genetics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Myriad Genetics Inc. June 4, 202698.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Coherus Oncology Inc. | Grant or award | +30,000 | — | — |
| Jun 4, 2026 | Myriad Genetics Inc. | Grant or award | +59,701 | — | — |
| Jun 5, 2025 | Myriad Genetics Inc. | Grant or award | +49,796 | — | — |
| Jun 6, 2024 | Myriad Genetics Inc. | Grant or award | +15,695 | — | — |
| May 13, 2024 | Myriad Genetics Inc. | Open-market sale | −6,200 | $25.30 | $156,860 |
| Jun 1, 2023 | Myriad Genetics Inc. | Grant or award | +15,151 | — | — |
Questions about Lee Nisley Newcomer
What boards is Lee Nisley Newcomer on?
Lee Nisley Newcomer sits on the boards of Coherus Oncology Inc. and Myriad Genetics Inc.
How long has Lee Nisley Newcomer served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.